Lataa...
Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis
BACKGROUND AND PURPOSE: Cilostazol, a phosphodiesterase 3’ inhibitor, is used in Asia-Pacific countries for stroke prevention, but rarely used elsewhere. In addition to weak antiplatelet effects, it stabilizes endothelium, aids myelin repair and astrocyte-neuron energy transfer in laboratory models,...
Tallennettuna:
| Julkaisussa: | Stroke |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Lippincott Williams & Wilkins
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7382534/ https://ncbi.nlm.nih.gov/pubmed/32646330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.120.029454 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|